Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 19, 2018 at 10:10 AM EDT

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Clovis Oncology shares dropped on Friday after the company announced initial data from its Phase 2 clinical trial of Rubraca…

Chris Lange | Oct 19, 2018 at 9:15 AM EDT

Why Merrimack Pharma Is Terminating Its Midstage Lung Cancer Study

Merrimack Pharmaceuticals shares dropped early on Friday after the company announced that it would be terminating its midstage SHERLOC study…

Chris Lange | Oct 18, 2018 at 1:40 PM EDT

LogicBio Therapeutics Announces Potential Pricing for IPO

Genome editing company LogicBio Therapeutics expects to price more than 5 million shares for an initial public offering valued up…

Chris Lange | Oct 18, 2018 at 11:00 AM EDT

Why Proteostasis Shares Are Skyrocketing

Proteostasis Therapeutics shares absolutely exploded on Thursday after the company announced positive preliminary results from its early-stage cystic fibrosis trial.

Chris Lange | Oct 18, 2018 at 9:40 AM EDT

Are Endocyte Investors Getting Enough in the Buyout?

Endocyte shares were up sharply early Thursday after it was announced that the company would be acquired.

Chris Lange | Oct 17, 2018 at 8:30 AM EDT

Twist Bio Announces Potential Pricing for IPO

Synthetic biology company Twist Bioscience expects to price 5 million shares for an initial public offering valued up to more…

Chris Lange | Oct 16, 2018 at 10:15 AM EDT

Merck’s Pancreatic Cancer Treatment Gets FDA Nod

Merck shares were up handily on Tuesday after the company announced a key update from the FDA on its Lynparza…

Chris Lange | Oct 16, 2018 at 9:40 AM EDT

UnitedHealth Earnings Show Why It Is a Top Dow Stock

UnitedHealth released better-than-expected third-quarter financial results before the markets opened on Tuesday.

Chris Lange | Oct 16, 2018 at 8:35 AM EDT

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.

Chris Lange | Oct 15, 2018 at 1:30 PM EDT

What to Look For When UnitedHealth Reports on Tuesday Morning

UnitedHealth is scheduled to report its second-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 15, 2018 at 10:15 AM EDT

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the…

Chris Lange | Oct 12, 2018 at 11:25 AM EDT

Tetraphase Prepares for US Launch of Xerava

Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for…

Chris Lange | Oct 12, 2018 at 10:20 AM EDT

Why Corium Shares Are Booming

Corium shares jumped on Friday after the company announced that it entered into a definitive merger agreement under which Gurnet…

Chris Lange | Oct 11, 2018 at 1:20 PM EDT

How Compugen Is Weathering Thursday’s Storm

Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment…

Chris Lange | Oct 11, 2018 at 12:05 PM EDT

CRISPR Wins FDA Approval for Human Trials

CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration…

1 … 116 117 118 119 120 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Why Merrimack Pharma Is Terminating Its Midstage Lung Cancer Study

LogicBio Therapeutics Announces Potential Pricing for IPO

Why Proteostasis Shares Are Skyrocketing

Are Endocyte Investors Getting Enough in the Buyout?

Twist Bio Announces Potential Pricing for IPO

Merck’s Pancreatic Cancer Treatment Gets FDA Nod

UnitedHealth Earnings Show Why It Is a Top Dow Stock

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

What to Look For When UnitedHealth Reports on Tuesday Morning

What to Expect When Johnson & Johnson Reports Tuesday

Tetraphase Prepares for US Launch of Xerava

Why Corium Shares Are Booming

How Compugen Is Weathering Thursday’s Storm

CRISPR Wins FDA Approval for Human Trials

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live: Will Palantir Beat Q1 Earnings Tonight After Market Close?

How Nvidia’s Jensen Huang Used The Innovator’s Dilemma to Dominate

Meta Platforms vs Snap: Who’s Really Winning Digital Ads?

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

How Nvidia’s Jensen Huang Used The Innovator’s Dilemma to Dominate

Live: onsemi Q1 Earnings Tonight. Can the Stock Continue Its 90% YTD Rally?

Health and Healthcare Articles

All Health and Healthcare Articles

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Why Merrimack Pharma Is Terminating Its Midstage Lung Cancer Study

LogicBio Therapeutics Announces Potential Pricing for IPO

Why Proteostasis Shares Are Skyrocketing

Are Endocyte Investors Getting Enough in the Buyout?

Twist Bio Announces Potential Pricing for IPO

Merck’s Pancreatic Cancer Treatment Gets FDA Nod

UnitedHealth Earnings Show Why It Is a Top Dow Stock

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

What to Look For When UnitedHealth Reports on Tuesday Morning

What to Expect When Johnson & Johnson Reports Tuesday

Tetraphase Prepares for US Launch of Xerava

Why Corium Shares Are Booming

How Compugen Is Weathering Thursday’s Storm

CRISPR Wins FDA Approval for Human Trials

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live: Will Palantir Beat Q1 Earnings Tonight After Market Close?

How Nvidia’s Jensen Huang Used The Innovator’s Dilemma to Dominate

Meta Platforms vs Snap: Who’s Really Winning Digital Ads?

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how